Literature DB >> 5019641

Ethical and social issues in screening for genetic disease.

.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 5019641     DOI: 10.1056/NEJM197205252862104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Tay-Sachs disease: to screen or not to screen?

Authors:  Fred Rosner
Journal:  J Relig Health       Date:  1976-10

2.  Sickle cell counseling in a children and youth project.

Authors:  A Heimler; A Chabot
Journal:  Am J Public Health       Date:  1974-10       Impact factor: 9.308

3.  Planning for the economic and career impact of a sickle cell anemia program.

Authors:  J J McNamara
Journal:  Health Serv Rep       Date:  1974 May-Jun

4.  Some negative aspects of state health departments' policies related to screening for sickle cell anemia.

Authors:  I M Rutkow; J M Lipton
Journal:  Am J Public Health       Date:  1974-03       Impact factor: 9.308

Review 5.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

Review 6.  Incidental Findings of Sickle Cell Trait From an Everyday Diabetes Test: Should General Health Care Providers and Testing Centers Report, Retest, or Refer?

Authors:  Anna Cronin de Chavez; Karl M Atkin; Fiona Babbington; Maria J Berghs; Simon M Dyson; Adrian Miller; Donald C Whitelaw
Journal:  Clin Diabetes       Date:  2020-01

7.  Education, consent, and counseling in sickle cell screening programs: report of a survey.

Authors:  M R Farfel; N A Holtzman
Journal:  Am J Public Health       Date:  1984-04       Impact factor: 9.308

8.  Some influences on public participation in a genetic screening program.

Authors:  M H Becker; M M Kaback; I M Rosenstock; M V Ruth
Journal:  J Community Health       Date:  1975

9.  Attitudes of patients and their relatives to Huntington's disease.

Authors:  R Stern; R Eldridge
Journal:  J Med Genet       Date:  1975-09       Impact factor: 6.318

10.  Hemoglobinopathies in the Hamilton region. II. Thalassemia traits and iron therapy.

Authors:  M A Ali
Journal:  Can Med Assoc J       Date:  1975-03-22       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.